FilingReader Intelligence

Medplus Health subsidiary receives drug license suspension order

July 10, 2025 at 01:10 PM UTCBy FilingReader AI

Medplus Health Services announced that its subsidiary, Optival Health Solutions Private Limited, has received a suspension order for a Drug License for a store located in Andhra Pradesh. This regulatory action falls under SEBI guidelines concerning listing obligations and disclosure requirements. The suspension, effective from July 9, 2025, was issued by the Assistant Director and sales licensing authority in Andhra Pradesh. The suspension order pertains to a store situated at Nippo centre, Andhra Pradesh, and involves a temporary cessation of drug sales activities. The company estimates the potential revenue loss due to the seven-day suspension to be approximately INR~3.40lacs.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

News Alerts

Get instant email alerts when Medplus Health Services publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →